Swati Chandak
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 12, 2025
Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6.Swati Chandak, Sarega Gurudas, Raheeba Pakeer Muhammed
|Feb 21, 2025
Factors associated with achieving various visual acuity outcomes during loading doses of aflibercept 2 mg for treatment naïve exudative age-related macular degeneration: PRECISE Study Report 7.Swati Chandak, Sarega Gurudas, Raheeba Mohammed Pakeer
|May 06, 2024
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5.Sridevi Thottarath, Sarega Gurudas, Swati Chandak
|Apr 23, 2024
Subretinal transient hyporeflectivity in neovascular age-related macular degeneration and its response to a loading phase of aflibercept: PRECISE report 4.Andrea Montesel, Raheeba Pakeer Muhammed, Swati Chandak
|Feb 10, 2024
Optical Coherence Tomography Angiography as a Diagnostic Tool for Diabetic Retinopathy.Naomi Wijesingha, Wei-Shan Tsai, Ayse Merve Keskin
|Dec 15, 2023
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3.Shruti Chandra, Sarega Gurudas, Ian Pearce
Pageof 2
Frequent Collaborators
5 joint publications
Martin Mckibbin
5 joint publications
Benjamin Jl Burton
5 joint publications
Anna Grabowska
4 joint publications
Faruque Ghanchi
3 joint publications
Shruti Chandra
3 joint publications
Sobha Sivaprasad
2 joint publications
Victor Chong
2 joint publications
Ayse Merve Keskin
2 joint publications
Dimitrios Kazantzis
1 joint publications
Wei-Shan Tsai
